SUNNYVALE, Calif. June 12, 2025 /PRNewswire/ — SutiSoft Inc.
With this update, SutiSoft continues its commitment to innovation by integrating intelligent identity verification and regulatory-grade audit capabilities into its already robust eSignature solution. Businesses in highly regulated industries, including healthcare, life sciences, and pharmaceuticals, can now meet compliance mandates while improving signer confidence and process integrity.
The dynamic Knowledge Based Authentication (KBA) feature uses AI to generate real-time, personalized challenge questions that verify signer identity before granting access to documents. Administrators can define the accuracy level required to pass authentication, set the number of allowed attempts, and control how often a signer can attempt to access the document. These controls ensure that only verified users can view and sign sensitive documents, significantly reducing fraud risk and enhancing security.
SutiSign now fully supports 21 CFR Part 11, the FDA regulation that governs the use of electronic records and signatures. The online platform includes secure, time-stamped audit trails that cannot be altered, advanced authentication protocols, and reliable traceability of every action taken on a document.
The platform now supports online notarization, allowing users to remotely notarize documents anytime through a trusted notary network. It also integrates with leading payment gateways like Authorize.Net, Square, Stripe, Clover, and others, enabling users to sign documents and process payments securely in a single step.
With these enhancements, SutiSign continues to evolve as a robust, intelligent eSignature platform built for today’s compliance-driven business landscape.
SutiSoft develops a comprehensive suite of cloud-based SaaS platforms that streamlines the key business processes for enterprises of all sizes.
©
SutiSoft, Inc. All Rights Reserved
By clicking “Accept,” you agree that we may use cookies to enhance site functionality, understand usage patterns, and deliver relevant marketing content. Not providing or withdrawing consent may limit certain features or affect site functionality.